About Urinary excretory system Peptide Bundle – A-6 Vladonix A-12 Chitomur A-9 Pielotax
The natural combination for producting the Urinary excretory system is: A-6 Vladonix, A-12 Chitomur and ,A-9 Pielotax.
Stack Rationale & Synergy
- A-6 Vladonix: Modulates systemic immune surveillance (thymic peptide fraction).
Urinary Excretory Peptide Bundle Overview
This Khavinson-class short-peptide stack combines immune-thymus support with target renal-urothelial bioregulation. [1, 2, 3]
| Component | Target Organs | Primary Claim / Mechanism | Regulatory Status |
|---|---|---|---|
| A-6 Vladonix | Thymus / Immune | T-cell support, systemic resilience | Unevaluated (FDA/EMA) |
| A-9 Pielotax | Kidneys / Nephrons | Renal cell renewal, filtration support | Dietary supplement |
| A-12 Chitomur | Urinary bladder / Urothelium | Detrusor/smooth muscle tone support | Dietary supplement |
Stack Rationale & Synergy
- A-6 Vladonix: Modulates systemic immune surveillance (thymic peptide fraction).
- A-9 Pielotax: Targets renal parenchyma via short polypeptide fractions (e.g., AED/EDL homologs). [1, 2]
- A-12 Chitomur: Addresses lower urinary tract/bladder wall integrity. [1, 2]
-
Clinical & Safety Reality Check
- Regulatory gap: Short bioregulator peptides lack large-scale human randomized controlled trials (RCTs).
- Renal caution: Compromised GFR (Glomerular Filtration Rate) requires nephrologist oversight before adding exogenous tissue extracts.
- Total cost / dosing variance: Typically packaged in 20- or 60-capsule lots; linguistic vs. capsule forms alter mucosal absorption kinetics.
Reviews
There are no reviews yet.